glutathione metabolism breast cancer

glutathione metabolism breast cancer The crosstalk between and non-coding RNAs in progression and treatment resistance ER-phagy drives resistance to mitochondria-targeted

Name: glutathione metabolism breast cancer The crosstalk between and non-coding RNAs in progression and treatment resistance ER-phagy drives resistance to mitochondria-targeted
Brand: metron-ms.com
SKU: 9376204837
Price: 27.19 USD
Availability: InStock
Rating: 4.0648 (11 reviews)

ER phagy drives resistance to mitochondria targeted therapy in breast cancer ScienceDirect glutathione pathway breast cancer Targeting Metabolism: Partner in Crime in Anticancer Therapy Adipocyte derived glutathione promotes obesity related breast Frontiers Oxidative stress and antioxidants in breast cancer: a double edged sword glutathione epigenetic drug resistance A prismatic view of the epigenetic metabolic regulatory axis in breast cancer therapy Frontiers Epigenetic mechanisms of glutathione and tamoxfen Xanthine Metabolic Changes in Tamoxifen Resistant Breast Cancer Cell Lines are Mediated by Down Regulation of GS Taming glutathione potentiates metallodrug action

SKU: 9376204837 · From metron-ms.com

4.1

USD27.19 USD48.19

Pay in 4 interest-free payments of $6.80 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

Tsilou ET, Rubin BI, Reed G, Caruso RC, Iwata F, Balog J, Gahl WA, Kaiser-Kupfer MI (2006) Nephropathic cystinosis: posterior segment manifestations and effects of cysteamine therapy

Pharmaceutics 13:61

The 33.5% improvement rate with associated 1.9% mortality is noteworthy, particularly given that these patients had higher baseline disease severity (median MELD-3 18.7) compared to those who worsened (median MELD-3 16.4)